Well I have to say, management have lived up to their word and done well to control outgoings. I'm starting to believe that there is a lot of upside here now. Some more contracts and it's cashflow positive. Won't even take very much to ensure a profitable company if things continue to be managed well. I'm actually impressed from where they were not even a year ago. Well done!
- Forums
- ASX - By Stock
- Ann: Appendix 4C - June 2020 Quarterly Report
Well I have to say, management have lived up to their word and...
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SIS (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.013M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 6555928 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 3682977 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 6555928 | 0.003 |
12 | 11158668 | 0.002 |
8 | 20733211 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 3682977 | 4 |
0.005 | 6456092 | 5 |
0.006 | 3982517 | 8 |
0.007 | 3090001 | 5 |
0.008 | 669229 | 2 |
Last trade - 10.09am 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
SIS (ASX) Chart |
Day chart unavailable